Cancer Treatment

Immunotherapy Chemotherapy Breast Cancer CAR-T Cell Therapy Glioblastoma Prostate Cancer Pancreatic Cancer Bladder Cancer Lung Cancer Cervical Cancer

3 ARTICLES

last wk.

Dual-Mode 18F Tracer Shows Preclinical Promise for Image-Guided Prostate Cancer Surgery

UBC researchers report mouse data on a PSMA-targeted agent pairing PET imaging with intraoperative fluorescence, with GMP and toxicity studies required before human testing.

4 ARTICLES

last wk.

Paclitaxel Reengineered Into Self-Assembling Nanovesicle Shows Strong Preclinical Gains

3 ARTICLES

last wk.

First Targeted Treatment Eliminates Rare T-Cell Lymphoma After CAR T

3 ARTICLES

2w ago

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

3 ARTICLES

2w ago

Intratumoral Fc-Optimized CD40 Antibody Achieves Systemic Remissions in Phase 1 Study

6 ARTICLES

2w ago

TAR-200 Clears Tumors in 82% of High-Risk Bladder Cancer Patients, Advances to FDA Priority Review

3 ARTICLES

2w ago

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival

4 ARTICLES

2w ago

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

17 ARTICLES

3w ago

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

4 ARTICLES

4w ago

Dual-Species Bacterial Therapy Destroys Tumors Without Immune Cells

8 ARTICLES

4w ago

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

3 ARTICLES

4w ago

Meta-Analysis Shows 43% Overall Response for Fecal Transplants Combined with Cancer Immunotherapy

3 ARTICLES

4w ago

Preclinical Studies Confirm NKAPL as Lung Cancer Tumor Suppressor, Prompt Demethylation Therapy Development

9 ARTICLES

last mo.

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

3 ARTICLES

last mo.

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

3 ARTICLES

2mo ago

Early Temferon Trial Shows Engineered Macrophages Reprogram Glioblastoma Niche to Rescue CAR-T Cells

7 ARTICLES

2mo ago

Genomic Test Predicts Chemotherapy Resistance in Cancer Patients

Particle.news

Cancer Treatment

Dual-Mode 18F Tracer Shows Preclinical Promise for Image-Guided Prostate Cancer Surgery

Paclitaxel Reengineered Into Self-Assembling Nanovesicle Shows Strong Preclinical Gains

First Targeted Treatment Eliminates Rare T-Cell Lymphoma After CAR T

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

Intratumoral Fc-Optimized CD40 Antibody Achieves Systemic Remissions in Phase 1 Study

TAR-200 Clears Tumors in 82% of High-Risk Bladder Cancer Patients, Advances to FDA Priority Review

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Dual-Species Bacterial Therapy Destroys Tumors Without Immune Cells

Never miss stories about

Cancer Treatment

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

Meta-Analysis Shows 43% Overall Response for Fecal Transplants Combined with Cancer Immunotherapy

Preclinical Studies Confirm NKAPL as Lung Cancer Tumor Suppressor, Prompt Demethylation Therapy Development

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

NHS Opens Pre-Treatment Immunotherapy Trial for Glioblastoma

Nature Study Shows Gut Bacterium YB328 Boosts Cancer Immunotherapy

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Early Temferon Trial Shows Engineered Macrophages Reprogram Glioblastoma Niche to Rescue CAR-T Cells

Genomic Test Predicts Chemotherapy Resistance in Cancer Patients

Never miss stories about

Cancer Treatment